Package 45802-436-01

{"route": ["TOPICAL"], "spl_id": "710d0db0-54af-49fd-b2ed-77582a4b3238", "openfda": {"nui": ["N0000175607", "M0018962"], "unii": ["81BDR9Y8PS"], "rxcui": ["313199", "313201"], "spl_set_id": ["ffd11dee-4266-4201-9573-1e82c2d30a63"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (45802-436-01)  / 100 g in 1 TUBE", "package_ndc": "45802-436-01", "marketing_start_date": "20230605"}, {"sample": false, "description": "1 TUBE in 1 CARTON (45802-436-94)  / 30 g in 1 TUBE", "package_ndc": "45802-436-94", "marketing_start_date": "20230605"}], "brand_name": "TAZAROTENE", "product_id": "45802-436_710d0db0-54af-49fd-b2ed-77582a4b3238", "dosage_form": "GEL", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "45802-436", "generic_name": "tazarotene", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZAROTENE", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".5 mg/g"}], "application_number": "ANDA213079", "marketing_category": "ANDA", "marketing_start_date": "20230605", "listing_expiration_date": "20261231"}